Targeted Drug Formulation Delivery

Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.

16,419 US filings from 5,648 companies since 2023 · 2023: 4,117 · 2024: 5,171 · 2025: 5,007 · 2026 YTD: 2,124

Pharmaceutical PreparationsDrug Delivery Devices

Top companies

Ranked by filings in this theme since 2023. 2026 is partial.

#	Company	Since 2023	2023	2024	2025	2026 YTD	YoY
1	The Regents of the University of California	134	44	31	47	12	+51.6%
2	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	103	37	26	32	8	+23.1%
3	Regeneron Pharmaceuticals, Inc.	100	24	31	30	15	-3.2%
4	AMGEN INC.	85	21	21	33	10	+57.1%
5	ELI LILLY AND COMPANY	84	21	29	26	8	-10.3%
6	The Johns Hopkins University	80	30	21	19	10	-9.5%
7	Novartis AG	78	20	25	26	7	+4.0%
8	Board of Regents, The University of Texas System	74	23	22	23	6	+4.5%
9	Veradermics, Incorporated	74	·	·	29	45	—
10	Boston Scientific Scimed, Inc.	68	12	19	24	13	+26.3%
11	LTS Lohmann Therapie-Systeme AG	65	15	26	15	9	-42.3%
12	NOVO NORDISK A/S	65	23	17	15	10	-11.8%
13	ModernaTX, Inc.	63	11	16	27	9	+68.8%
14	ANTECIP BIOVENTURES II LLC	62	20	9	24	9	+166.7%
15	Flamel Ireland Limited	61	9	29	17	6	-41.4%
16	TRANSLATE BIO, INC.	60	10	22	21	7	-4.5%
17	Hoffmann-La Roche Inc.	57	21	15	15	6	0.0%
18	The Board of Trustees of the Leland Stanford Junior University	55	12	21	15	7	-28.6%
19	Pfizer Inc.	54	14	22	11	7	-50.0%
20	The Brigham and Women's Hospital, Inc.	53	23	11	14	5	+27.3%
21	ARCUTIS BIOTHERAPEUTICS, INC.	48	11	21	14	2	-33.3%
22	The Procter & Gamble Company	48	16	19	10	3	-47.4%
23	Chugai Seiyaku Kabushiki Kaisha	47	9	18	14	6	-22.2%
24	CORNELL UNIVERSITY	46	11	15	16	4	+6.7%
25	AstraZeneca AB	45	9	12	18	6	+50.0%